Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis

被引:38
作者
Avni, Reut [1 ]
Cohen, Batya [1 ]
Neeman, Michal [1 ]
机构
[1] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
基金
美国国家卫生研究院; 欧洲研究理事会; 以色列科学基金会;
关键词
hypoxia; angiogenesis; glycolysis; metastasis; oxidative stress; imaging; MRI; POSITRON-EMISSION-TOMOGRAPHY; ELECTRON-PARAMAGNETIC-RESONANCE; ENDOTHELIAL GROWTH-FACTOR; QUANTITATIVE TISSUE OXIMETRY; INTERSTITIAL FLUID PRESSURE; MAGNETIC-RESONANCE; IN-VIVO; MATRIX METALLOPROTEINASES; VASCULAR-PERMEABILITY; OXYGEN DYNAMICS;
D O I
10.1002/nbm.1632
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Tumors emerge as a result of the sequential acquisition of genetic, epigenetic and somatic alterations promoting cell proliferation and survival. The maintenance and expansion of tumor cells rely on their ability to adapt to changes in their microenvironment, together with the acquisition of the ability to remodel their surroundings. Tumor cells interact with two types of interconnected microenvironments: the metabolic cell autonomous microenvironment and the nonautonomous cellular-molecular microenvironment comprising interactions between tumor cells and the surrounding stroma. Hypoxia is a central player in cancer progression, affecting not only tumor cell autonomous functions, such as cell division and invasion, resistance to therapy and genetic instability, but also nonautonomous processes, such as angiogenesis, lymphangiogenesis and inflammation, all contributing to metastasis. Closely related microenvironmental stressors affecting cancer progression include, in addition to hypoxia, elevated interstitial pressure and oxidative stress. Noninvasive imaging offers multiple means to monitor the tumor microenvironment and its consequences, and can thus assist in the understanding of the biological basis of hypoxia and microenvironmental stress in cancer progression, and in the development of strategies to monitor therapies targeted at stress-induced tumor progression. Copyright (C) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:569 / 581
页数:13
相关论文
共 123 条
[1]  
Aboagye EO, 1998, CANCER RES, V58, P1063
[2]  
Abramovitch R, 1999, CANCER RES, V59, P5012
[3]   Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR [J].
Ardenkjaer-Larsen, JH ;
Fridlund, B ;
Gram, A ;
Hansson, G ;
Hansson, L ;
Lerche, MH ;
Servin, R ;
Thaning, M ;
Golman, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) :10158-10163
[4]   Hypoxia-inducible factor-1 and oncogenic signalling [J].
Bárdos, JI ;
Athcroft, M .
BIOESSAYS, 2004, 26 (03) :262-269
[5]   Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].
Bergers, G ;
Brekken, R ;
McMahon, G ;
Vu, TH ;
Itoh, T ;
Tamaki, K ;
Tanzawa, K ;
Thorpe, P ;
Itohara, S ;
Werb, Z ;
Hanahan, D .
NATURE CELL BIOLOGY, 2000, 2 (10) :737-744
[6]  
Bhujwalla Z M, 1999, Top Magn Reson Imaging, V10, P92, DOI 10.1097/00002142-199904000-00002
[7]   Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-At1 tumor [J].
Bourke, Vincent A. ;
Zhao, Dawen ;
Gilio, Joseph ;
Chang, Cheng-Hui ;
Jiang, Lan ;
Hahn, Eric W. ;
Mason, Ralph P. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (04) :1179-1186
[8]   Assessing tumor angiogenesis using macromolecular MR imaging contrast media [J].
Brasch, R ;
Pham, C ;
Shames, D ;
Roberts, T ;
vanDijke, K ;
vanBruggen, N ;
Mann, J ;
Ostrowitzki, S ;
Melnyk, O .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1997, 7 (01) :68-74
[9]   In vivo molecular target assessment of matrix metalloproteinase inhibition [J].
Bremer, C ;
Tung, CH ;
Weissleder, R .
NATURE MEDICINE, 2001, 7 (06) :743-748
[10]   Glucose transporters: Structure, function and consequences of deficiency [J].
Brown, GK .
JOURNAL OF INHERITED METABOLIC DISEASE, 2000, 23 (03) :237-246